EUCTR2015-001809-14-BE进行中（未招募）1 期
Beta-Lactams (ceftazidime, piperacilline-tazobactam, meropenem) dosing scheme validation in septic hemodialysed patient
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-patient undergoing hemodiafiltration dialysis with chronic or acute kidney disease
- •-filtration rate less than 10ml/min
- •- intravenous antibiotherapy by either ceftazidim, piperacilline/tazobactam or meropenem
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 25
排除标准
- •-septic shock
- •-pregnancy
- •-dosage higher than recommanded for meningitis, osteitis or mucoviscidosis
- •-under 18 years old
- •-prophylaxia antibiotics treatment
- •-obeses treatment defined as a BMI higher than 40kg/m²
研究者
相似试验
招募中
3 期
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care UnitSepsisSeptic ShockNCT05565222Assistance Publique - Hôpitaux de Paris600
招募中
4 期
Continuous infusion antipseudomonalbeta-lactams for acute infective exacerbations in cystic fibrosis: a prospective randomised controlled trialAcute pulmonary exacerbation of cystic fibrosisInfection - Studies of infection and infectious agentsRespiratory - Other respiratory disorders / diseasesHuman Genetics and Inherited Disorders - Cystic fibrosisACTRN12612000945820Dr Anton Peleg120
尚未招募
不适用
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA PatientsPost-cardiac SurgeryExtracorporeal Membrane Oxygenation ComplicationInfectionsCardiac ArrestCardiogenic ShockNCT06338345University Hospital, Grenoble225
已完成
不适用
REsistance to BEta-Lactam antibiotics due to extended-spectrum beta-lactamases in the Netherlandsdragerschap van ESBL-producerende bacteriëncarriage with ESBL-producing bacteriacarriage of resistant bacteriaNL-OMON36316Vrije Universiteit Medisch Centrum2,700
尚未招募
3 期
Assessment of prolongation of life with 2 different chemotherapy regimens - Gemcitabine – Cisplatin – Nab-Paclitaxel (GAP) and gemcitabine-platinum (GP) combination in advanced gallbladder cancers.CTRI/2024/01/061479Tata Memorial Centre